Six Years After Legalization: NHS Still Failing to Provide Access to Medical Cannabis

When the UK rescheduled cannabis six years ago, it marked a historic turning point—a beacon of hope for patients in need and a gateway for cannabis entrepreneurs. Despite this milestone, the journey toward effective patient access remains fraught with obstacles, particularly within the public sector. A recent report from the Cannabis Industry Council (CIC) highlights […]

Scaling Responsibly: Lessons for Cannabis Startups from MedMen and Eaze

Cannabis startups are springing up worldwide, driven by increasing legalization and shifting public attitudes. However, the industry’s complex regulatory landscape and unique challenges make sustainable scaling a daunting task. Companies like MedMen and Eaze offer valuable lessons on the potential pitfalls and opportunities in this space. Here’s how startups can learn from their experiences to […]

BREAKING NEWS – Spain’s Slow Burn: Navigating the Tight Regulations of Medical Cannabis

Spain is making gradual progress in regulating medical cannabis, with the Ministry of Health moving forward with a Real Decreto (Royal Decree) to establish a framework for its therapeutic use. However, the approach remains conservative, especially compared to other European nations that are advancing both medicinal and recreational cannabis regulations. What the Royal Decree Proposes […]

BREAKING NEWS – New Opportunities in Czechia: Seize the Moment!

The cannabis landscape in Czechia is on the verge of a significant transformation, opening up fresh opportunities for cannabis founders. The recent proposal by the Czech Ministry of Justice could reshape the industry, making it legal for adults over 21 to grow up to three cannabis plants and possess up to 50 grams of dried […]

Is the Medical THC Market Dead in Italy? Challenges and Opportunities in 2024

The Italian medical cannabis market, once a rising star in Europe, now faces significant headwinds that are testing its resilience. With the recent banning of low-THC hemp products, or “cannabis light,” the outlook for medical THC products might seem grim. However, while the recreational and light hemp sectors are under threat, the medical cannabis industry […]

The Status of Cannabis in Japan: Legal Framework and Emerging Opportunities for Cannabis Entrepreneurs

As Japan makes notable strides in the global cannabis landscape, the country’s evolving legal framework offers both challenges and opportunities for cannabis entrepreneurs. With the recent shift towards criminalizing personal cannabis use while allowing broader access to medical marijuana and CBD products, the cannabis sector in Japan is poised for a transformation. Strict Legal Framework […]

The Global Shift in Cannabis Policy by data: Insights from the US and Germany

The US Perspective: Rescheduling Cannabis The proposal to reschedule cannabis from Schedule I to Schedule III in the United States marks a significant shift in federal drug policy. Historically, Schedule I drugs are classified as having a high potential for abuse and no accepted medical use, making them illegal to prescribe under federal law. Cannabis […]

Greece’s Medical Cannabis Milestone: Ending a Seven-Year Journey to Healthcare Innovation

After a protracted seven-year wait filled with anticipation and hurdles, Greece has officially introduced medical cannabis to its healthcare system, marking a significant milestone in patient care and treatment options. Monday, February 19, became a historic day as the first medical cannabis products became available to patients with a prescription, heralding what industry stakeholders have […]